Pharmaceutical Executive

Pharm Exec aims to be a platform for industry leaders to share their thoughts, experiences, and insights on new business and marketing concepts, strategies, and methods. We encourage contributions from the pharmaceutical community and frequently publish articles authored by its members.

National, Trade/B2B

English

Magazine

Outlet metrics

Domain Authority

Ranking

Global

#679932

United States

#337531

Health/Biotechnology and Pharmaceuticals

#285

Traffic sources

Monthly visitors

Articles

Crucial Technological Advancements for Future Pandemic Preparedness and Supply Chain Stability

2 months ago | pharmexec.com | Miranda Schmalfuhs

Marcel Botha, CEO of 10XBeta, identifies the most significant technological innovations in medical device manufacturing that will be crucial for future pandemic preparedness and supply chain stability.
Strategizing for an Uncertain Trade War: Q&A with Anshul Mangal

Mar 19, 2025 | pharmexec.com | Michael Hollan

The Project Farma president discusses various ways the tariffs could impact the industry and how businesses can prepare or react.
How Technology is Impacting Launch Strategy Timelines

Feb 24, 2025 | pharmexec.com | Michael Hollan

John Arena, interim president of global pharma services at Cencora, discusses how new technologies are shortening timelines.
Pharma Marketing's Top Movers and Shakers in 2024

Dec 20, 2024 | pharmexec.com

These professionals in the healthcare marketing sector have been chosen by their peers for making big moves and taking on larger roles.
Pharma Pulse 11/12/24: Takeaways From Midlife MS Patients, The Power of Simplicity for First-in-Human Studies & more

Nov 13, 2024 | pharmexec.com | Miranda Schmalfuhs

The latest news for pharma industry insiders.
Pharma Marketing Trends to Expect in 2025

Oct 22, 2024 | pharmexec.com | Miranda Schmalfuhs

In this part of her video interview, Amanda Powers-Han, Chief Marketing Officer, Greater Than One and Pharmaceutical Executive Advisory Board Member identifies marketing trends you expect to be big right away in 2025.
How Moderna is Implementing AI and ChatGPT

Jun 6, 2024 | pharmexec.com | Miranda Schmalfuhs

In this part of his Pharmaceutical Executive video interview, Brice Challamel, Vice President, AI Products & Platforms, Moderna, discusses how AI, specifically GPTs, have had a significant impact on Moderna's mission.
Evaluate Acquires J+D Forecasting

Jan 10, 2024 | pharmexec.com | Michael Hollan

Evaluate announced the acquisition of J+D Forecasting, a provider of forecasting solutions focused on the pharmaceutical and life sciences industry. The move will bring J+D under the Norstella umbrella, the parent company of Evaluate. The parent company also includes Citeline, MMIT, Panalgo, and The Dedham Group. Norstella works to bring therapies to patients and provide insights to pharmaceutical companies during the drug development life cycle.
HBA Announces 2024 Woman of the Year

Jan 9, 2024 | pharmexec.com | Michael Hollan

Dr. Yvonne Greenstreet is the 2024 Healthcare Businesswomen's Association (HBA) Woman of the Year. Greenstreet is the CEO of Alnylam, a pharmaceutical company focused on developing RNA interference therapeutics. The HBA also named Dr. Otis Johnson as its honorable mentor of the year, and awarded Dr. Katherine Schoenborn its annual STAR honor. The HBA will honor Greenstreet at its annual Woman of the Year event, which will take place on May 10 in New York City.
With Most Fortune 500 Companies Unprepared for New SEC Cyber Regulations, What Should Their Board of Directors Do? A Q&A with Dr. Herb Lin, Senior Research Scholar for Cybersecurity at Stanford University

Jan 8, 2024 | pharmexec.com | Michael Wong

Dr. Herb Lin is a senior research scholar for cyber policy and security at the Center for International Security and Cooperation and Hank J. Holland Fellow in Cyber Policy and Security at the Hoover Institution, both at Stanford University. In 2016, he served on President Obama's Commission on Enhancing National Cybersecurity. He is co-author of "Bytes, Bombs, and Spies-The Strategic Dimensions of Offensive Cyber Operations" published by The Brookings Institution Press.